Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05446259 · ClinicalTrials.gov registry record

Degenerative Cervical Myelopathy Repository

A clinical trial of Cervical Myelopathy, sponsored by Francis Farhadi.

Recruiting
Registry status
245
Enrollment target
1
Study location

NCT05446259 is a study of Cervical Myelopathy that is actively recruiting participants, run by Francis Farhadi. The registered enrollment target is 245 participants, above the 58-participant average among 4 other Cervical Myelopathy trials with a reported enrollment target (322% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05446259, a study of Cervical Myelopathy, is actively recruiting participants, sponsored by Francis Farhadi.

RECRUITING
Registry status
245 participants
Enrollment target
1
Study location

Study Summary

To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.

Conditions Studied

Interventions

  • OTHER Standard clinical care procedures and outcome measurements.

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 245 participants
Start Date 2022-07-13
Est. Completion 2028-05

Sponsor

Francis Farhadi

8 total trials

What the Registry Record Tells You About NCT05446259

The ClinicalTrials.gov registry entry for NCT05446259 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 4 other Cervical Myelopathy trials with a reported enrollment target (322% higher). The listed sponsor is Francis Farhadi, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Myelopathy appearing as the primary indexed condition, and to 1 intervention - of which Standard clinical care procedures and outcome measurements. is the first listed.

NCT05446259 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05446259 about?

NCT05446259 is a clinical study titled "Degenerative Cervical Myelopathy Repository". To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic p...

What is the current status of trial NCT05446259?

This trial is currently recruiting. The enrollment target is 245 participants. The study started on 2022-07-13. Estimated completion is 2028-05.

What conditions does trial NCT05446259 study?

This clinical trial studies the following conditions: Cervical Myelopathy.

What interventions are being tested in trial NCT05446259?

The interventions under investigation include: Standard clinical care procedures and outcome measurements. (OTHER).

Who is sponsoring clinical trial NCT05446259?

This trial is sponsored by Francis Farhadi, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05446259 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Myelopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.